Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000821091 | SCV000961834 | pathogenic | Glycogen storage disease, type V | 2021-04-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu132Profs*10) in the PYGM gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with PYGM-related disease. Loss-of-function variants in PYGM are known to be pathogenic (PMID: 8316268, 16786513). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000821091 | SCV002793167 | likely pathogenic | Glycogen storage disease, type V | 2022-03-11 | criteria provided, single submitter | clinical testing | |
Gharavi Laboratory, |
RCV000722868 | SCV000853999 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research |